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Abstract
Background: Growth-differentiation factor-15 (GDF-15) is a stress-responsive, transforming growth factor-b-related
cytokine, which has recently been reported to be elevated in serum of patients with idiopathic pulmonary arterial
hypertension (IPAH). The aim of the study was to examine the expression and biological roles of GDF-15 in the
lung of patients with pulmonary arterial hypertension (PAH).
Methods: GDF-15 expression in normal lungs and lung specimens of PAH patients were studied by real-time RT-
PCR and immunohistochemistry. Using laser-assisted micro-dissection, GDF-15 expression was further analyzed
within vascular compartments of PAH lungs. To elucidate the role of GDF-15 on endothelial cells, human
pulmonary microvascular endothelial cells (HPMEC) were exposed to hypoxia and laminar shear stress. The effects
of GDF-15 on the proliferation and cell death of HPMEC were studied using recombinant GDF-15 protein.
Results: GDF-15 expression was found to be increased in lung specimens from PAH patients, com-pared to normal
lungs. GDF-15 was abundantly expressed in pulmonary vascular endothelial cells with a strong signal in the core of
plexiform lesions. HPMEC responded with marked upregulation of GDF-15 to hypoxia and laminar shear stress.
Apoptotic cell death of HPMEC was diminished, whereas HPMEC proliferation was either increased or decreased
depending of the concentration of recombinant GDF-15 protein.
Conclusions: GDF-15 expression is increased in PAH lungs and appears predominantly located in vascular
endothelial cells. The expression pattern as well as the observed effects on proliferation and apoptosis of
pulmonary endothelial cells suggest a role of GDF-15 in the homeostasis of endothelial cells in PAH patients.
Background
GDF-15 is a protein belonging to the TGF-beta family,
which includes several proteins involved in tissue home-
ostasis, differentiation, remodeling and repair [1]. As a
pleiotropic cytokine it is involved in the stress response
program of different cell types after cellular injury.
Under normal conditions, GDF-15 is only weakly
expressed in most tissues [2]. However GDF-15 is
strongly upregulated in disease states such as acute
injury, tissue hypoxia, inflammation and oxidative stress
[3-6].
In the cardiovascular system, GDF-15 is expressed in
cardiomyocytes and other cell types including macro-
phages, endothelial cells, vascular smooth muscle cells,
and adipocytes [1,7,8]. In endothelial cells (ECs) it has
been shown that GDF-15 inhibits proliferation, migra-
tion and invasion in vitro and in vivo [9-11]. A recent
study demonstrated that the inhibitory effect of GDF-15
on EC proliferation was only present at higher
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concentrations (5 ng/ml), GDF-15 caused endothelial
cell proliferation and was proangiogenic [12]. At present
little is known about the expression of GDF-15 in the
lung. In situ hybridization studies in rats have revealed
expression of GDF-15 in bronchial epithelial cells [1].
GDF-15 is potently induced in animal models of lung
injury. Bleomycin administration in adult mice and pro-
longed hyperoxic exposure in neonate mice resulted in
GDF-15 induction [5].
Pulmonary arterial hypertension (PAH) is a life-threa-
tening disease characterized by a marked and sustained
elevation of pulmonary artery pressure that results in
right ventricular (RV) failure and death [13]. Histologi-
cally, remodeling of pulmonary arteries show various
degrees of medial hypertrophy and endothelial cell
growth, which ultimately lead to the obliteration of pre-
capillary arteries [14,15]. The mechanisms resulting in
pulmonary vascular remodeling are complex and incom-
pletely understood. Several members of the TGF-b
superfamily have been implicated in this process [16]
while the role of GDF-15 in the pathophysiology of
PAH is not clear. In a recent study we demonstrated
elevated serum levels of GDF-15 in patients with idio-
pathic pulmonary arterial hypertension (IPAH) [17].
Furthermore, it has been shown that GDF-15 serum
levels are increased in scleroderma patients with pul-
monary hypertension and GDF-15 protein was predomi-
nantly located in monocytes infiltrating the lung tissue
[18].
In the present study we investigated the expression of
GDF-15 in human normal lungs and in lung tissue from
patients with PAH. In addition, we conducted in vitro-
studies to elucidate the possible role of GDF-15 in the
pulmonary vasculature.
Methods
Human tissue samples
Lung tissue was obtained from 5 brain-dead organ
donors and explanted lungs from 7 patients with PAH
(IPAH, n = 4, congenital heart disease-associated PAH,
n = 3) at the time of lung transplantation. Formalin-
fixed, paraffin-embedded lung tissue specimens were
obtained from the Institute of Pathology at Hannover
Medical School following the guidelines of the local
ethics committee. Complex vascular lesions in PAH
patients were diagnosed by two experienced pathologists
(FL, DJ) according to well-established histopathological
criteria [19].
Immunohistochemical staining
Formalin-fixed, paraffin-embedded sections (3 μm) of
normal controls and PAH lungs were deparaffinized.
The endogenous peroxidase was blocked with 3% H2O2
for 10 min. GDF-15 staining was performed using a
polyclonal monospecific antibody (1:20, Rabbit anti-
human HPA011191, Sigma-Aldrich, Munich, Germany)
after epitope retrieval with Protease XXIV (Sigma-
Aldrich, Munich, Germany, 10 min, 37°C). Primary anti-
body was incubated for one hour at room temperature
and visualised in brown with diaminobenzidine (DAB)
as substrate for horseradish peroxidase (PolyHRP detec-
tion system, Zytomed Systems, Berlin, Germany). Sec-
tions were counterstained with Hemalaun. Negative
controls were performed using a rabbit IgG isotype con-
trol (Dianova, Hamburg, Germany, diluted like the pri-
mary antibody). Healthy placental tissue [20] (Additional
file 1 - panel A) and prostate cancer tissue [18,21]
(Additional file 1 - panel B) served as control for GDF-
15 immunostaining. Exemplary staining (Additional file
2) was also performed using Goat anti-human GDF-15
IgG antibody (1:25, R&D Systems, cat. no. AF957).
Microdissection of plexiform lesions
Formalin-fixed, paraffin-embedded (FFPE) tissue sec-
tions 5 μm were mounted on a poly-L-lysin-coated
membrane fixed onto a metal frame. After standard
deparaffinization and hemalaun staining, the CellCut
Plus system (MMI Molecular Machines & Industries
AG, Glattbrugg, Switzerland) was used for laser-assisted
microdissection. Distinct anatomical lung structures
(plexiform lesions, normal arteries) were isolated using a
no-touch technique, essentially as described earlier by
our group [22]. Approximately 850 cells were harvested
from serial sections in each compartment.
Real-time RT-PCR
Extraction of total RNA and cDNA synthesis was per-
formed as previously described (20). Real-time RT-PCR
was performed on an ABI PRISM 7700 Sequence Detec-
tor (Applied Biosystems, Foster City, CA, USA). CT
values were calculated by normalization to the mean
expression of two endogenous controls (b-GUS and b-
actin) and converted into 2
-DDCT values. For calculation
of relative expression levels, the weakest signal in the
control group was set equal to one, with all other values
being calculated relative to this level. The primer pair
for GDF-15 (Applied Biosystems, ID: Hs00171132_m1)
was: GDF-15 (forward: CAC ACCGAAGACTCCAGA,
reverse: CCGAGAGATACGCAGGT;A m p l i c o ns i z e
78 bp).
Cell culture experiments
Human pulmonary microvascular endothelial cells
Human pulmonary microvascular endothelial cell-line
(HPMEC) clone ST1.6R (kindly pro-vided by Prof. C.J.
Kirkpatrick, Institute of Pathology, Johannes-Gutenberg
University of Mainz) was maintained in Earles Medium
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ml endothelial cell growth supplement, 2 mM Glutamax,
sodium heparin (25 μg/ml) and 1% penicillin/streptomy-
cin. Cells were cultured at 37°C, 5% CO2 and passaged
2-3 times weekly using trypsin-EDTA. The cell line was
characterized earlier as endothelial cells by the presence
of platelet endothelial cell adhesion molecule (PECAM,
CD 31), von Willebrand factor (vWF), intercellular
adhesion molecule (ICAM-1), vascular cell adhesion
molecule-1 (VCAM-1) and E-selectin [23]. Previous stu-
dies have demonstrated the endothelial cell properties of
the cell line [24,25].
Hypoxic treatment
HPMEC maintained in Earles Medium 199 and supple-
mented with 20% fetal calf serum was seeded in 6-well
plates and grown to 70-80% confluence. Hypoxia was
induced in a hypoxia incubator chamber (Billups-
Rothenberg, San Diego, USA) [26] for various time peri-
ods ranging between 2-12 hours. Cell viability and cell
death assays were performed 2 h after hypoxia
induction.
Shear stress exposure
Shear stress experiments were performed in a modified
cone-and-plate apparatus utilized for generating defined
fluid shear stresses [27], consisting of a stainless steel
cone rotating over a base 6-well plate that contains plas-
tic coverslip inserts. The entire apparatus was main-
tained in a 5% CO2/95% air humidified atmosphere
thermostatically regulated at 37°C. Fluid mechanical
parameters were adjusted to subject the endothelial
monolayers (HPMEC) to a laminar shear stress of 5 and
15 dynes/cm
2 (1 dyne = 100 mN) for 6 h, which reflects
physiological shear stress in major human arteries that
ranges between 5-20 dyn/cm
2 [28]. Replicate-plated con-
trol coverslips were incubated under static conditions
for the same time period.
Assessment of cell growth
For assessment of cell viability after hypoxic treatment,
HPMEC were grown to 80% conflu-ence in 96-well plates.
Ten minutes before starting hypoxic treatment, various
concentrations (1 ng/ml to 100 ng/ml) of GDF-15 were
added to each well. Cell vitality was measured using the
CellTiter 96 Aqueous One solution cell proliferation assay
(Promega, Madison, USA) according to the manufacturer’s
protocol. Absorbance of the formazan product was mea-
sured at 490 nm (Versamax tunable microplate reader,
Molecular Devices, Sunnyvale, USA) [29].
Assessment of cell death
To induce endothelial cell death, HPMEC were exposed
to hypoxia as described above. To identify endothelial
cell death, double staining with Annexin-V-FLUOS
(Roche, Mannheim, Germany) and propidium iodide
(Sigma-Aldrich, Munich, Germany) was performed in
HPMEC either in absence or presence of GDF-15 (5 ng/
ml or 50 ng/ml). In addition, double staining with
Hoechst-33342 and sytox green (both Invitrogen Mole-
cular Probes, Karlsruhe, Germany) was performed as
described earlier [30]. The activity of caspase-3 and 7 in
HPMEC cell extracts was detected using the Apo-ONE
homogenous caspase-3/7 assay (Pro-mega, Mannheim,
Germany), according to the manufacturer’sp r o t o c o l .
Fluorescence was detected at an excitation wavelength
of 499 nm with emission maximum at 521 nm (Versa-
max tunable microplate reader, Molecular Devices, Sun-
nyvale, USA).
In vitro angiogenesis assay
Endothelial cell spheroids were prepared as described by
Korff et al. [31]. HPMEC were suspended in a corre-
sponding medium containing 20% methocel-stock solu-
tion (Earles Medium 199 + 1.2% methyl-cellulose (w/v);
Sigma-Aldrich, Munich, Germany). A defined number
of cells were seeded in the wells of a non-adherent
round-bottom 96 well plate (Greiner, Frickenhausen,
Germany) to form single spheroids with a defined num-
ber of cells (750) and size within 24 h at 37°C and 5%
CO2 in humidified atmosphere. In vitro angiogenesis in
collagen gels was quantified using spheroids of HPMEC
as described by Korff et al. [31].
Western Blot Analysis
Immunoblotting was performed as described earlier [32].
Polyclonal goat anti-human GDF-15 IgG antibody (R&D
Systems, cat. no. AF957) was used to determine GDF-15
expression in HPMEC. Antibodies against b-actin, Akt,
and Ser473-phospho-Akt were obtained from Sigma-
Aldrich (Munich, Germany) or by New England Biolabs
(Ipswich, USA).
GDF-15 Sandwich IRMA
GDF-15 protein in supernatants of HPMEC was mea-
sured using an immunoradiometric sandwich assay as
described previously [33]. In these experiments a poly-
clonal goat anti-human GDF-15 IgG antibody (R&D
Systems, cat. no. AF957) was used.
Statistical analysis
Values are presented as mean ± SD. Gaussian distribu-
tion of the values was evaluated using the Kolmogorov-
Smirnov test. Comparisons between groups were tested
by Student’s t-test or Mann-Whitney test where appro-
priate. Significances between more than two groups
were determined by one-way analysis of variance
(ANOVA), followed by Student-Newman-Keuls post-
hoc test or by Kruskal-Wallis test where appropriate. A
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nificance. Analyses were performed using SPSS16.0 and
GraphPad Prism version 5.01.
Results
GDF-15 expression in lungs of patients with PAH
GDF-15 mRNA expression in whole lung tissue was
assessed using real-time RT-PCR. Com-pared to normal
lung tissue, GDF-15 expression was 5-fold increased in
lung tissue from PAH patients (Figure 1). To assess pro-
tein expression of GDF-15 in human lung we performed
immunohistochem-istry studies. In normal lung, GDF-
15 was noted in endothelial cells of small pulmonary
arteries as well as in alveolar macrophages (Figure 2).
Smooth muscle cells and epithelial cells exhibited only a
weak signal. In PAH lungs GDF-15 protein expression
was observed in the endothelial cell layers of pulmonary
arteries with medial hypertrophy, whereas little or no
GDF-15 protein expression could be detected in the
smooth muscle cells of remodeled pulmonary arteries
(Figure 3). In concentric lesions GDF-15 expression was
noted in cells lining the small lumen of lesions, probably
endothelial cells (Figure 4). In plexiform lesions, an
intense signal for GDF-15 protein was observed in the
cells lining the vascular channels (Figure 5). There were
no differences in the cellular expression pattern of GDF-
15 in IPAH (Figure 5) and PAH due to Eisenmenger’s
physiology (Figure 6). As a negative control we used a
rabbit IgG isotype control which was lacking a staining
signal (Figure 7). To confirm the GDF-15 expres-sion
patterns seen in the immunohistochemistry studies,
laser-assisted micro-dissections of vascular compart-
ments from normal lungs and PAH lungs were per-
formed (Figure 8). Transcripts for GDF-15 were ampli-
fied from laser-captured vascular cells of normal
pulmonary arteries and plexiform lesions of PAH
patients by using quantitative RT-PCR. Compared to
Figure 1 GDF-15 mRNA expression in normal human lung.
GDF-15 mRNA expression in normal lung and lung tissue from
patients with pulmonary arterial hypertension (PAH) was assessed
by real-time RT-PCR. Data are presented as relative expression of
GDF-15 mRNA normalized to two housekeeping genes. Data from
n = 5 each group are shown as mean ± SD. * = p < 0.05 vs. normal
lung.
Figure 2 GDF-15 immunohistochemistry in normal human lung
tissue. Note the staining of endothelial cells in small pulmonary
arteries (arrow). Insets depicts a high-power view, highlighting the
expression of GDF-15 in endothelial cells. Smooth muscle cells
exhibit a weaker signal (arrowhead). Alveolar macrophages show a
strong signal for GDF-15 (asterisks). A weak signal for GDF-15 was
noted in alveolar and bronchial epithelial cells. Original
magnifications: × 100; Inset a × 200, inset b × 300.
Figure 3 GDF-15 immunohistochemistry in pulmonary arterial
hypertension (PAH). GDF-15 protein expression in PAH) showing a
strong signal in the endothelial cell layer (arrows) of a pulmonary
artery with media hypertrophy. The smooth muscle cells
(arrowheads) of the remodeled pulmonary artery are lacking
significant GDF-15 protein expression. Macrophages around the
pulmonary artery stain positive for GDF-15 (asterisks). Original
magnification: × 200.
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transcripts was detected in plexiform lesions of patients
with PAH. To study the cellular composition of plexi-
form lesions, transcripts for the endothelial cell marker
CD31 and eNOs as well as the smooth muscle cell mar-
ker myosin heavy chain were also amplified from micro-
dissected vascular cells (Additional file 3). Compared to
t h ev e s s e lw a l lo fn o r m a la r t e r i e se x p r e s s i o no fC D 3 1
and eNOS was increased in plexiform lesions. On the
other hand, the smooth muscle cell marker myosin
heavy chain was also expressed in microdissected cells
from plexiform lesions suggesting a heterogenous cellu-
lar composition of these vascular structures.
GDF-15 expression in response to hypoxia and laminar
shear stress
HPMEC were exposed to hypoxia for various time peri-
ods. mRNA and protein levels for GDF-15 were deter-
mined using quantitative RT-PCR (Figure 9, panel A),
IRMA (Figure 9, panel B) and Western Blot analysis
(Figure 9, panel C). Hypoxia increased GDF-15 expres-
Figure 4 GDF-15 immunohistochemistry in a concentric lesion
of a patient with PAH. Immunoreactiv-ity for GDF-15 is observed
in cells lining the small remaining lumen of the concentric lesion
(asterisk). Inset depicts a high-power view of the GDF-15 positive
cells, which are probably endothelial cells (arrowheads). Original
magnifications: × 200; Inset × 400.
Figure 5 GDF-15 immunohistochemistry in a plexiform lesion
of a patient with IPAH. Immunohisto-chemical localization of GDF-
15 protein in lung tissue of a patient with idiopathic pulmonary
arterial hyperten-sion (IPAH). Intense signal for GDF-15 is seen in the
cells of a plexiform lesion (P). Inset exhibits prominent luminal
staining of GDF-15 in cells lining the vascular channel (arrow). Note
the presence of GDF-15 in the endothelial cells of neigbouring small
capillaries (arrowheads). Original magnifications: × 200; Inset × 400.
Figure 6 GDF-15 immunohistochemistry in a patient with PAH
and Eisenmenger physiology. Intense signal for GDF 15 is noted
in cells lining vascular channels. Inset shows prominent luminal
staining of GDF-15 in endothelial cells (arrowhead). Note lower
signal for GDF-15 in the connective tissue around the plexiform
lesion, which probably represents GDF-15 bound to extracellular
matrix (dashed arrows). Original magnifications: × 200; Inset × 400.
Figure 7 Negative Control. Representative photo of a plexiform
lesion using a rabbit IgG isotype control for immunohistochemistry.
Original magnifications: × 200.
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detected after 2 hours at mRNA level and after 4 hours
at protein level. After 10 hours there was a 12-fold
upregulation of GDF-15 mRNA. Western Blot analysis
from HPMEC exposed to hypoxia showed a strong
upregulation of the secreted 30 kDa form of GDF-15.
To assess the effects of shear stress on the mRNA
expression of GDF-15, HPMEC were exposed to laminar
flow (5 and 15 dynes/cm
2) for 6 h in a cone-and-plate
apparatus. Laminar shear stress (5 dynes/cm
2)r e s u l t e d
in a 2-fold upregulation of GDF-15 transcripts com-
pared to static controls (0 dynes/cm
2). By increasing the
laminar flow to 15 dynes/cm
2, a 10-fold upregulation of
GDF-15 mRNA was noted (Figure 10).
Effect of GDF-15 on proliferation of pulmonary
endothelial cells
To investigate the angiogenic effects of GDF-15 on
HPMEC proliferation, a rapid colorimetric proliferation
assay was performed [29]. At a concentration of 5 ng/ml
recombinant GDF-15 protein significantly increased
endothelial cell proliferation at different time points ran-
ging from 12 h to 48 h (Figure 11, panel A). Whereas 50
ng/ml recombinant GDF-15 incubated for 6 to 48 hours
showed a significant inhibition of endothelial cell prolif-
eration (Figure 11, panel B).
Figure 8 GDF-15 mRNA expression amplified from laser-
assisted microdissection. Distinct anatomical lung structures
(plexiform lesions, normal arteries) of patients with severe PAH were
isolated using laser-assisted microdissection techniques. Relative
mRNA expression was assessed by real-time RT-PCR. Data are
presented as relative expression of GDF-15 mRNA normalized to
two housekeeping genes. Data from n = 4 in each group are
shown as mean ± SD. * = p < 0.05 vs. normal artery.
Figure 9 Upregulation of GDF-15 by hypoxia in endothelial cells. Human pulmonary microvascular endothelial cells (HPMEC) were
subjected to hypoxia for various time periods (2 h to 24 h). The mRNA and protein levels of GDF-15 (secreted form) were determined either by
quantitative RT-PCR (panel A), immunoradiometric sandwich assay - IRMA (panel B) or Western Blot analysis (panel C). Hypoxia increased GDF-15
expression in a time dependent manner, which was initially detected after 2 hours on mRNA level and after 4 hours on protein level. Data from
n = 4 each group are shown as mean ± SD. *p < 0.05 compared to control.
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cells
To investigate the angiogenic effects of GDF-15 sprout-
ing of human pulmonary microvascu-lar endothelial
cells (HPMEC) was assessed using a three-dimensional
spheroid sprouting assay. Compared to control (Figure
11, panel C), recombinant GDF-15 protein at a concen-
tration of 5 ng/ml increased endothelial cell sprouting
(Figure 11, panel D), whereas at higher concentrations
(50 ng/ml) sprouting was decreased (Figure 11, panel E).
GDF-15 affects endothelial cell death in response to
hypoxia
HPMEC were exposed to hypoxia to induce apoptosis. In
our hypoxia system the most prom-inent induction of
apoptosis was observed after 8-12 hours. Apoptotic cell
death was assessed by measuring the activities of caspases
3 and 7 (Figure 12, panel A), two of the key executioners
of apoptosis, and by determining the number of Annexin
V-positive/propidium iodide-negative cells (Figure 12,
panel B). Recombinant GDF-15 protein at a concentra-
tion of either 5 or 50 ng/ml reduced hypoxia-induced
Figure 10 Upregulation of GDF-15 by shear stress.H u m a n
pulmonary microvascular endothelial cells (HPMEC) were exposed
to laminar fluid flow (5 and 15 dynes/cm
2) for 6 h. Expression of
GDF-15 mRNA was assessed by quantitative RT-PCR. Data are
presented as relative expression of GDF-15 mRNA normalized to
two housekeeping genes (b-GUS and b-actin). Data from n = 5
each group are shown as mean ± SD. * = p < 0.05 compared to
static control (0 dynes/cm
2).
Figure 11 Effect of GDF-15 on endothelial cell proliferation and sprouting. Proliferation of human pulmonary microvascular endothelial
(HPMEC) cell was assessed using a rapid colorimetric proliferation assay. At a concentration of 5 ng/ml recombinant GDF-15 led to increased
HPMEC proliferation (panel A), whereas a reduction of HPMEC proliferation (panel B) was seen at higher concentration of GDF-15 (50 ng/ml).
Data from n = 5 each group are shown as mean ± SD. * = p < 0.05 vs. control. Sprouting of human pulmonary microvascular endothelial cells
(HPMEC) was assessed using a three-dimensional spheroid sprouting assay. Compared to control (panel C), recombinant GDF-15 protein at a
concentration of 5 ng/ml increased endothelial cell sprouting (panel D), whereas at higher concentrations (50 ng/ml) sprouting was decreased
(panel E). Five spheroids per group and per experiment were analyzed.
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nant GDF-15 protein (50 ng/ml) for 30 to 240 minutes
resulted in an induction of Akt phosphorylation deter-
mined by immunoblotting (Figure 13).
Discussion
In the present study we demonstrated that GDF-15 is
expressed in human lung tissue, arising predominantly
in macrophages and pulmonary endothelial cells. Com-
pared to normal lung, GDF-15 appears upregulated in
lung tissue of patients with PAH, especially in areas of
active vascular remodeling, i.e. plexiform lesions. Since
GDF-15 protein influences proliferation and apoptosis
of pulmonary endothelial cells, it might play a role in
the evolution and homeostasis of plexiform lesions in
PAH patients.
GDF-15 is a stress-responsive cytokine that is upregu-
lated under pathologic conditions involving various sti-
muli such as tissue hypoxia, inflammation, or enhanced
oxidative stress [3-6]. Under physiologic conditions
Figure 12 Effect of GDF-15 on endothelial cell death. Human pulmonary microvascular endothelial cells (HPMEC) were exposed to hypoxia
within an incubator chamber filled with a gas mixture of 0,2% oxygen, 5% carbon dioxide and 94,8% nitrogen placed in a 37°C incubator.
Apoptotic cell death was either assessed by measuring the activity of the caspases 3 and 7 (panel A) and by determining the number of
Annexin V-positive cells (panel B). Recombinant GDF-15 at a concentration of 5 and 50 ng/ml) reduced hypoxia-induced apoptotic cell death.
Data from n = 5 in each group are shown as mean ± SD. * = p < 0.05 compared to control.
Figure 13 Akt phosphorylation by GDF-15 in endothelial cells. GDF-15 induced Akt phosphorylation at Ser437 in human pulmonary
microvascular endothelial cells (HPMEC). The cells were stimulated with recombinant GDF-15 protein (50 ng/ml) for 30 to 240 minutes. Akt and
Ser437 were determined by immunoblotting. An exemplary blot from n = 3 experiments is presented.
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organs [34]. It is therefore unsurprising that we only
detected a weak immunostaining signal for GDF-15 in
human normal lung tissue with almost no expression in
the airways like bronchial and alveolar epithelial cells.
As demonstrated in previous studies [18], GDF-15 was
strongly expressed in alveolar macrophages which might
indicate a role of this protein in innate immunity [2].
Interestingly, our immunostaining experiments clearly
demonstrated strong expression of GDF-15 in the vascu-
lar compartment of PAH patients, particularly in the
intima of pulmonary arteries. GDF-15 staining was
observed in pulmonary vessels of all sizes, beginning
from the microvasculature up to large pulmonary ves-
sels. The endothelial expression pattern was observed in
normal lung as well as in lungs from PAH patients, sug-
gesting a physiological role for GDF-15 in pulmonary
endothelial cells. To date little is known about the func-
tional role of GDF-15 in endothelial cells. A previous
study demonstrated inhibitory effects of GDF-15 on pro-
liferation, migration and invasion of endothelial cells in
vitro as well as anti-angiogenic effects in vivo using a
matrigel-plug-assay [11]. In contrast to these findings, a
recently published paper demonstrated both angiogenic
and anti-angiogenic properties of GDF-15 [12], which
were concentration-dependent. GDF-15 elicited pro-
angiogenic effects at low concentrations, whereas para-
doxical effects were observed at higher concentrations
(100 ng/ml). In accordance with this finding we too
were able to demonstrate concentration-dependent pro-
as well as anti-angiogenic effects of recombinant GDF-
15 protein on pulmonary endothelial cells in vitro. That
different concentrations of a cytokine could result in dif-
ferent cellular responses is well-known for members of
the TGF-b-family. For instance, TGF-b1 exerts bi-func-
tional effects on endothelial cells, regarding activation,
proliferation and migration. At low concentrations TGF-
b1 has a stimulating effect, whereas higher concentra-
tions inhibit these processes [35]. It is challenging to
speculate the active amount of GDF-15 in the pulmon-
ary vasculature. However, addi-tional autocrine and
paracrine pathways may determine the local concentra-
tion of GDF-in the vascular compartment. Furthermore,
a variety of activating or disabling regulators may inter-
fere with the intra- and extracellular storage as well as
the stability of GDF-15 in lung compartments.
Compared to normal lung tissue, increased GDF-15
expression was observed in PAH lungs, with strongest
expression being identified in areas of vascular remodel-
ing, especially in the cells forming the plexiform lesions.
In comparison, GDF-15 expression was lower in vascu-
lar smooth muscle cells, both in normal vessels and in
remodeled arterioles with media hypertrophy. No differ-
ences in the expression pattern of GDF-15 were seen
between lungs of various underlying aetiologies of pul-
monary hypertension such as IPAH, and PAH due to
Eisenmenger’s physiology. A recent study identified
expression of GDF-15 protein in pulmonary macro-
phages of patients with PAH due to scleroderma, but
almost no GDF-15 staining in IPAH lungs [18]. This
staining pattern appears to conflict with our results, but
may be related to different protocols of tissue prepara-
tion and staining. To confirm the expression pattern
seen in our immunohistochemical studies we performed
laser-assisted microdissection of vascular subcompart-
ments in PAH lungs. We successfully amplified GDF-15
transcripts in plexiform lesions and cells from morpho-
logical normal pulmonary arteries of PAH patients. In
accordance to the immunohistochemical staining pat-
tern, increased GDF-15 expression was detected in
plexiform lesions compared to unremodeled pulmonary
arteries. These findings suggest that GDF-15 could be
involved in the pathobiology of plexiform lesions as
opposed to the muscular compartment. The cellular and
cytokine environment of plexiform lesions, which are
characterized by disorganized focal proliferation of
endothelial channels [36,37], is complex and not fully
understood. Since a variety of different cytokines and
signaling pathways interact with each other, it is difficult
t od e f i n et h ep r e c i s er o l eo fas i n g l ec y t o k i n ei ns u c ha
complex milieu. Key players in vascular remodeling of
PAH lungs are members of the TGF-b-superfamily, and
TGFb1 has been reported to potentiate intimal hyper-
plasia in animal models following arterial injury [38].
Factors triggering expression of GDF-15 in the pul-
monary vasculature remain unclear. Since GDF-15 is a
stress responsive cytokine speculation remains that
inflammation and oxidative stress trigger expression of
GDF-15 in plexiform lesions. Indeed, several studies
have demonstrated increased oxidative stress and
inflammation within plexiform lesions [39]. Our findings
indicate that hypoxia is a potent stimulator of GDF-15
expression in pulmonary endothelial cells. Furthermore
shear stress might lead to induction of GDF-15 expres-
sion in the pulmonary vasculature. Given that in severe
PAH, plexiform lesions tend to form at bifur-cations
[40] where shear stress is likely to be high, we examined
whether shear stress affects GDF-15 expression. We
were able to demonstrate that shear stress leads to an
upregulation of GDF-15 expression in human microvas-
cular endothelial cells. These findings may be significant,
regarding the evolution of an apoptosis-resistant
endothelial cell phenotype. Previous reports have shown
that shear stress has an anti-apoptotic effect on
endothelial cells [41]. Since shear stress is a potent indu-
cer of GDF-15 in endothelial cells it is possible that the
anti-apoptotic effect provoked by shear stress is - at
least partly - mediated by GDF-15. In our study we
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Page 9 of 11were able to demonstrate that GDF-15 caused an induc-
tion of Akt phosphorylation and had a prosurvival effect
on endothelial cells. This finding is in accordance with
documented anti-apoptotic effects of GDF-15 in cardio-
myocytes involving the phosphoinositide 3-OH kinase
(PI3K) and Akt-dependent signaling pathways [32]. The
net effect of GDF-15 on cell proliferation, apoptosis and
pulmonary vascular remodeling is difficult to evaluate,
especially as GDF-15 is not the only player among the
mediators orchestrating vascular remodeling. Like other
members of the TGF-b-family proteins, GDF-15 exe-
cutes a wide variety of complex and ambiguous func-
tions, depending on cell type, microenvironment and
genetic status of the cell.
Conclusions
In conclusion, GDF-15 is up-regulated in lungs from
patients with PAH where it is mainly located in vascular
endothelial cells and plexiform lesions. The induction of
GDF-15 expression by shear stress and hypoxia in com-
bination with its effects on cell proliferation and apopto-
sis suggests a functional role of this protein in
pulmonary endothelial cells and thereby in the patho-
biology of complex vascular lesions in PAH lungs.
Additional material
Additional file 1: GDF-15 immunohistochemistry in human placenta
and prostate cancer. GDF-15 protein expression (brown staining)
assessed by immunohistochemistry in normal placental tissue (panel A)
and prostate cancer tissue (panel B). Original magnifications: × 100.
Additional file 2: GDF-15 immunohistochemistry using a Goat anti-
human GDF-15 IgG antibody. Immunohistochemical localization of
GDF-15 protein in lung tissue of a patient with idiopathic pulmonary
arterial hypertension (IPAH) using Goat anti-human GDF-15 IgG antibody
(R&D Systems). A signal for GDF-15 was seen in macrophages and cells
of a plexiform lesion. Original magnifications: × 200.
Additional file 3: Expression of endothelial cell and smooth muscle
cell marker in plexiform lesions. Distinct anatomical lung structures
(plexiform lesions, normal arteries) of patients with severe PAH were
isolated using laser-assisted microdissection techniques. Relative mRNA
expression was assessed by real-time RT-PCR. Data are presented as
relative expression of CD31, eNOS and myosin heay chain mRNA
normalized to two housekeeping genes. Data from n = 4 in each group
are shown as mean ± SD. * = p < 0.05 vs. normal artery.
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